Despite nonsignificant differences observed in the context of ER status, PR status, breast cancer grade, Her2 status and the distinction between DCIS and invasive cancer, our investigation showed an association between tumour sizes and AI’s output. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.